Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CPC Corporation, Taiwan, primarily known as a state-owned energy giant, operates a significant Biotechnology Business Unit (BBU) established in 2002 to diversify its industrial capabilities. The BBU leverages advanced microbial fermentation and chemical engineering technologies to produce high-value life science products, including medical-grade hyaluronic acid and health supplements. Its product portfolio features natural extracts such as Monascus (Red Yeast Rice) and Antrodia cinnamomea, marketed under the Zong-He brand for cardiovascular and hepatic health. Headquartered in Taipei with manufacturing facilities in Chiayi, the unit serves as a key player in Taiwan's bio-based material and functional food sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiwan CPC.